All filters
Videos
Pharmacogenetics - Back to reality | Andrew Owen, BSS, MSC, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Videos
Looking Backwards: Hormonal Contraception and ARTv | Kimberly Scarsi, PharmD, MS, FCCP
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Videos
Janssen - Rilpivirine | Herta Crauwels, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Videos
Target Concentrations | Angela Kashuba, PharmD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Videos
The FDA Perspective on Hepatitis C Drug Resistance | Patrick Harrington, PHD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Videos
Other Viruses: using Wolbachia to interrupt transmission of viral infections such as Dengue, Chikungunya and Zika | Steven Kern, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Videos
Improving PI drug resistance scores | Jens Verheyen, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
PI remain important options for first line | Linos Vandekerckhove, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Maintenance Therapy - What is the scientific/ virological rational | Charles Boucher, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
HIV attachment Inhibitors - Educational lecture in collaboration with ESAR | Thomas Klimkait, MD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
Roadblocks to implementation | Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
HIV in Europe 2020 – what will it look like? | Carlo Federico Perno, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2016
Videos
What challenges remain in viral hepatitis | Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
HCV elimination program in Georgia: Successes and challenges | Nikoloz Chkhartishvili, MD, MS, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
NASH and NAFLD in HIV: same or different? | Mariana Machado, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Non liver and survival benefits of SVR in HCV | Marion Peters, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
The use of HIV+ or HCV+ organs in transplantation | Stefano Fagiuoli, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Pharmacologist's perspective | David Back, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017